1. Home
  2. DSGN vs INBK Comparison

DSGN vs INBK Comparison

Compare DSGN & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • INBK
  • Stock Information
  • Founded
  • DSGN 2017
  • INBK 1999
  • Country
  • DSGN United States
  • INBK United States
  • Employees
  • DSGN N/A
  • INBK N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • INBK Major Banks
  • Sector
  • DSGN Health Care
  • INBK Finance
  • Exchange
  • DSGN Nasdaq
  • INBK Nasdaq
  • Market Cap
  • DSGN 208.9M
  • INBK 211.4M
  • IPO Year
  • DSGN 2021
  • INBK N/A
  • Fundamental
  • Price
  • DSGN $7.14
  • INBK $22.49
  • Analyst Decision
  • DSGN
  • INBK Hold
  • Analyst Count
  • DSGN 0
  • INBK 3
  • Target Price
  • DSGN N/A
  • INBK $30.67
  • AVG Volume (30 Days)
  • DSGN 189.7K
  • INBK 33.0K
  • Earning Date
  • DSGN 11-06-2025
  • INBK 10-22-2025
  • Dividend Yield
  • DSGN N/A
  • INBK 1.01%
  • EPS Growth
  • DSGN N/A
  • INBK N/A
  • EPS
  • DSGN N/A
  • INBK 1.76
  • Revenue
  • DSGN N/A
  • INBK $106,219,000.00
  • Revenue This Year
  • DSGN N/A
  • INBK $5.27
  • Revenue Next Year
  • DSGN N/A
  • INBK $27.40
  • P/E Ratio
  • DSGN N/A
  • INBK $13.44
  • Revenue Growth
  • DSGN N/A
  • INBK 4.74
  • 52 Week Low
  • DSGN $2.60
  • INBK $19.54
  • 52 Week High
  • DSGN $7.77
  • INBK $43.27
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 65.47
  • INBK 36.88
  • Support Level
  • DSGN $5.98
  • INBK $23.89
  • Resistance Level
  • DSGN $6.61
  • INBK $24.40
  • Average True Range (ATR)
  • DSGN 0.38
  • INBK 0.81
  • MACD
  • DSGN 0.04
  • INBK -0.16
  • Stochastic Oscillator
  • DSGN 99.62
  • INBK 5.57

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

Share on Social Networks: